| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/23/2002 | US20020061295 Myocardial grafts and cellular compositions useful for same |
| 05/23/2002 | US20020061294 Mononuclear phagocytes in therapeutic drug delivery |
| 05/23/2002 | US20020061293 Transduced human hematopoietic stem cells |
| 05/23/2002 | US20020061291 For screening potential drugs for toxicity toward introduced cells or capacity to stimulate differentiation and/or proliferation; cancer diagnosis |
| 05/23/2002 | DE10106512C1 Preparation of biological tissue, useful for making implants, especially of heart muscle, by growing cells on net- or felt-like collagen support |
| 05/23/2002 | DE10057755A1 New nucleic acid encoding plant phosphomevalonate kinase, useful for identifying modulators, potentially useful as herbicides and growth regulators |
| 05/23/2002 | CA2429460A1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | CA2429455A1 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | CA2429342A1 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
| 05/23/2002 | CA2429142A1 Maize yellow stripe1 and related genes |
| 05/23/2002 | CA2428850A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2002 | CA2428754A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | CA2428748A1 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 05/23/2002 | CA2428350A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | CA2427902A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | CA2427010A1 Transporters and ion channels |
| 05/22/2002 | EP1207208A2 Method for preservation of cells and nucleic acid targets |
| 05/22/2002 | EP1207203A2 DNA sequence and papillomavirus vaccine |
| 05/22/2002 | EP1207200A1 High affinity choline transporter |
| 05/22/2002 | EP1207196A1 Immortalized preosteoblasts and method for their production |
| 05/22/2002 | EP1206576A1 Novel kinases and uses thereof |
| 05/22/2002 | EP1206573A1 26 human secreted proteins |
| 05/22/2002 | EP1206570A1 Screening for udp-glucose:glycoprotein glucosyltransferase (uggt) activity |
| 05/22/2002 | EP1206563A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 05/22/2002 | EP1206562A2 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 05/22/2002 | EP1206560A2 Plant gene expression, controlled by constitutive plant v-atpase promoters |
| 05/22/2002 | EP1206558A2 Plants with modified polyunsaturated fatty acids |
| 05/22/2002 | EP1206553A2 Isomerase proteins |
| 05/22/2002 | EP1206549A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 05/22/2002 | EP1206548A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 05/22/2002 | EP1206544A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 05/22/2002 | EP1206543A2 Membrane associated proteins |
| 05/22/2002 | EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule |
| 05/22/2002 | EP1206540A2 Dna sequences isolated from human colonic epithelial cells |
| 05/22/2002 | EP1206533A1 Novel response element |
| 05/22/2002 | EP1206530A1 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 05/22/2002 | EP1206529A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 05/22/2002 | EP1206525A2 Method for growing stem cells |
| 05/22/2002 | EP1206493A2 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 05/22/2002 | EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 05/22/2002 | EP1206487A2 Notch receptor ligands and uses thereof |
| 05/22/2002 | EP1206479A1 A polynucleotide encoding a human junctional adhesion protein (jam-2) |
| 05/22/2002 | EP1206477A1 Cloning of the streptomyces avermitilis genes for glycosylation of avermectin aglycones |
| 05/22/2002 | EP1206283A2 Improved cellular uptake of bioactive agents |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1206225A2 In vitro repair of bone and/or cartilage defects |
| 05/22/2002 | EP1123004B1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 05/22/2002 | EP1107996B1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 05/22/2002 | EP0929564A4 High level expression of proteins |
| 05/22/2002 | EP0452364B1 Method for preparing water soluble polypeptides |
| 05/22/2002 | EP0437599B1 Cell lineages expressing a biologically active factor ix |
| 05/22/2002 | CN1350587A Acquired resistance genes in plants |
| 05/22/2002 | CN1350585A i(Neisseria meningitidis) polypeptide BASBO52 |
| 05/22/2002 | CN1350579A 葡萄糖脱氢酶 Glucose dehydrogenase |
| 05/22/2002 | CN1350578A Recombinant influenza viruses for vaccines and gene therapy |
| 05/22/2002 | CN1350549A Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 05/22/2002 | CN1350465A Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetiques |
| 05/22/2002 | CN1350059A Human embryonic stem cell obtained by freezing-unfreezing embryo |
| 05/22/2002 | CN1085076C Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
| 05/21/2002 | US6392125 Method for producing the transformants of coffee plants and transgenic coffee plants |
| 05/21/2002 | US6392118 Stable cultures; for controlling cell distribution within artificial organ |
| 05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| 05/21/2002 | US6392027 Mammalian adrenocorticotropic hormone receptor nucleic acids |
| 05/21/2002 | US6392026 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 05/21/2002 | US6392024 Nucleotide sequences coding freeze resistant polypeptide; for use in food processing and organ transplants |
| 05/21/2002 | US6392023 Nucleotide sequences which codes preferential polypeptide for use in serodiagnostics and vaccine development |
| 05/21/2002 | US6392022 Gene originating in human chondrocyte |
| 05/21/2002 | US6392020 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical compostion and a diagnostic reagent comprising the same |
| 05/21/2002 | US6392018 Polypeptides for use in the treatment of pathologies associated with inflammatory respone, nervous system disorders and leukemias; for use as a molecular weight control; for use in foods |
| 05/21/2002 | US6392016 Preferential polypeptide for use in the diagnosis and treatment of tumors; antiproliferative agents |
| 05/21/2002 | US6391858 Gene delivery in various muscle cell types; gene therapy for expression of erythropoietin to treat blood disorders such as anemias, for example |
| 05/21/2002 | US6391853 Human tissue inhibitor of metalloproteinase-4 |
| 05/21/2002 | US6391640 Methods and compositions for cellular and metabolic engineering |
| 05/21/2002 | US6391639 Regulatory sequence for use generating transgenic plants; for use in expression of heterologus genes in plants |
| 05/21/2002 | US6391637 Activating genetically engineered cells to generate preferential immunoglobulins; obtain cells, incubate with preferential polypeptides, recover preferential immunoglobulins |
| 05/21/2002 | US6391634 Monoclonal antibodies and their production and use |
| 05/21/2002 | US6391633 Genetically engineered cells for use as tools in the expression of heterologous genes |
| 05/21/2002 | US6391632 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 05/21/2002 | US6391613 Motor proteins and methods for their use |
| 05/21/2002 | US6391612 Replicating preferential plasmids; obtain nuclelotide sequences, transform cells, allow replication, recover plasmids |
| 05/21/2002 | US6391606 Peptides; for use in the develoment of human diagnostic and therapeutic agents |
| 05/21/2002 | US6391603 Genes of purine biosynthesis from Ashbya gossypii and the use thereof in microbial riboflavin synthesis |
| 05/21/2002 | US6391601 Transport protein for use in the treatment of cell proliferation defects, cancer, hyperplasias, restenosis, cardiovascular, immune and inflammatory disorders |
| 05/21/2002 | US6391589 Human chemokine beta-10 mutant polypeptides |
| 05/21/2002 | US6391580 Ras proteins |
| 05/21/2002 | US6391579 Nucleotide sequences coding transport protein for use in the treatment of thyroid defects |
| 05/21/2002 | US6391574 AFC1 and RCE1: isoprenylated CAAX processing enzymes |
| 05/21/2002 | US6391569 Method to detect Dirofilaria immitis infection |
| 05/21/2002 | US6391566 Drug screening of ligands which interact with receptor of defined amino acid sequence incubating by incubating ligand with recombinant cell or membrane which expresses receptor |
| 05/21/2002 | US6391554 Detecting cancerous conditions by assaying for telomerase activity |
| 05/21/2002 | US6391553 Analyzing level of gene expression of epsilon 4 or epsilon 2 alleles of apolipoprotein e; mutation in consensus sequence binding a transcription factor and either increase in epsilon 4 or decrease in epsilon 2 indicate disease |
| 05/21/2002 | US6391552 Enhancing transfection efficiency of vectors by recursive recombination |
| 05/21/2002 | US6391547 Microbial β-glucuronidase genes, gene products and uses thereof |
| 05/21/2002 | US6391543 Screening sample for preferential nucleotide sequences; incubate sample with nucleotide sequences, monitor sample for signal indicating bound nucleotide sequences |
| 05/21/2002 | US6391311 Polypeptide comprising amino acid sequence at least about 80% identical to specified sequence, which has biological activity of promoting selective growth and/or survival of human umbilical vein endothelial cells in in vitro assay |
| 05/21/2002 | US6391299 Anti-factor IX/IXa antibodies |
| 05/21/2002 | US6391297 Differentiation of adipose stromal cells into osteoblasts and uses thereof |
| 05/21/2002 | CA2215745C Human stat4 |
| 05/21/2002 | CA2215310C Substrates for beta-lactamase and uses thereof |